Get risk ready for 2018

Published: 27-Apr-2018 Featured companies: NSF
Regulatory Pharmaceutical

NSF's new pharma journal focuses on risk management, with a detailed article on becoming risk smart and a closer look into ICH Q9, quality risk management

NSF believe that the key to business success is to become less risk averse and more risk smart. In this short and concise document, NSF discuss key issues relating to risk management for pharmaceutical companies such as the fear of taking risks, complacency in the work place, ageing facilities and more.

Click here to access the pdf.

Featured companies

Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party...
See more

You may also like

Regulatory

One in four European pharma companies at risk of regulatory breaches according to NSF research

Read more
The independent survey exposed significant gaps in quality systems, supply chain oversight and data integration, just as EU GMP regulations continue to tighten

Trending Articles

  1. A-Z Color advances automated quality control in pharmaceutical label production EyeC inspection systems help deliver zero-error labels and GMP-compliant reliability
  2. IMed Group appoints Parminder Kalle as Chief Commercial Officer Parminder Kalle to lead IMed’s new chapter of international growth
  3. BioDuro appoints Yaohui Ji as Global President, CMC to accelerate expansion of integrated CRDMO capabilities BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), announced the appointment of Mr. Yaohui Ji as Global President, CMC
  4. QInscribe unveils AI-powered medical writing to revolutionise regulatory submissions New medical writing service provider QInscribe reduces the time to generate a draft clinical study report (CSR) by 90% with a generative AI solution
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    From stockpiles to smart supply chains: how industry wants to fix Europe’s drug shortages An EU-level stockpile may work, but only if it’s flexible, closely monitored and built with logistics in mind. Industry players say drug security will depend less on volume and more on data, digital oversight and early collaboration throughout the supply chain

Relevant companies

See more

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

You may also like

Regulatory

One in four European pharma companies at risk of regulatory breaches according to NSF research

The independent survey exposed significant gaps in quality systems, supply chain oversight and data integration, just as EU GMP regulations continue to tighten
Manufacturing

Redefining QP training for today’s professionals

How NSF is making specialist learning more flexible and accessible
Manufacturing

NSF’s QP training program combines technical skill with personalised guidance

A mentoring-led approach supporting delegates through every stage of the QP journey
Manufacturing

How to execute a successful remediation strategy

NSF’s experts share guidance on building sustainable compliance and avoiding quick fixes
Manufacturing

How to optimise your quality culture and maturity for success

NSF outlines how aligning culture, leadership and systems can strengthen compliance and performance
Manufacturing

What to expect from a regulatory inspection

NSF’s expert guide outlines key expectations, common pitfalls and strategies for lasting inspection readiness
Manufacturing

FDA US agent services backed by regulatory expertise

Helping medical device companies achieve smooth US market entry
Subscribe now